292 related articles for article (PubMed ID: 11076709)
1. Bronchiolitis-associated mortality and estimates of respiratory syncytial virus-associated deaths among US children, 1979-1997.
Shay DK; Holman RC; Roosevelt GE; Clarke MJ; Anderson LJ
J Infect Dis; 2001 Jan; 183(1):16-22. PubMed ID: 11076709
[TBL] [Abstract][Full Text] [Related]
2. Severe bronchiolitis and respiratory syncytial virus among young children in Hawaii.
Yorita KL; Holman RC; Steiner CA; Effler PV; Miyamura J; Forbes S; Anderson LJ; Balaraman V
Pediatr Infect Dis J; 2007 Dec; 26(12):1081-8. PubMed ID: 18043442
[TBL] [Abstract][Full Text] [Related]
3. Impact of severe disease caused by respiratory syncytial virus in children living in developed countries.
Simoes EA; Carbonell-Estrany X
Pediatr Infect Dis J; 2003 Feb; 22(2 Suppl):S13-8; discussion S18-20. PubMed ID: 12671448
[TBL] [Abstract][Full Text] [Related]
4. Mortality in children from influenza and respiratory syncytial virus.
Fleming DM; Pannell RS; Cross KW
J Epidemiol Community Health; 2005 Jul; 59(7):586-90. PubMed ID: 15965143
[TBL] [Abstract][Full Text] [Related]
5. Pre-existing disease is associated with a significantly higher risk of death in severe respiratory syncytial virus infection.
Thorburn K
Arch Dis Child; 2009 Feb; 94(2):99-103. PubMed ID: 18653625
[TBL] [Abstract][Full Text] [Related]
6. Severity of respiratory syncytial virus bronchiolitis is affected by cigarette smoke exposure and atopy.
Bradley JP; Bacharier LB; Bonfiglio J; Schechtman KB; Strunk R; Storch G; Castro M
Pediatrics; 2005 Jan; 115(1):e7-14. PubMed ID: 15629968
[TBL] [Abstract][Full Text] [Related]
7. Epidemiology of respiratory syncytial virus infection in northern Taiwan, 2001-2005 -- seasonality, clinical characteristics, and disease burden.
Lee JT; Chang LY; Wang LC; Kao CL; Shao PL; Lu CY; Lee PI; Chen JM; Lee CY; Huang LM
J Microbiol Immunol Infect; 2007 Aug; 40(4):293-301. PubMed ID: 17712463
[TBL] [Abstract][Full Text] [Related]
8. Respiratory syncytial virus pneumonia in the hospital setting: length of stay, charges, and mortality.
Howard TS; Hoffman LH; Stang PE; Simoes EA
J Pediatr; 2000 Aug; 137(2):227-32. PubMed ID: 10931416
[TBL] [Abstract][Full Text] [Related]
9. Immunopathogenesis of respiratory syncytial virus bronchiolitis.
Bennett BL; Garofalo RP; Cron SG; Hosakote YM; Atmar RL; Macias CG; Piedra PA
J Infect Dis; 2007 May; 195(10):1532-40. PubMed ID: 17436234
[TBL] [Abstract][Full Text] [Related]
10. Prophylaxis in RSV infection (Palivizumab)--is it worthwhile?
Hashmi NA; Cosgrove JF; MacMahon P
Ir Med J; 2000 Dec; 93(9):284. PubMed ID: 11209917
[TBL] [Abstract][Full Text] [Related]
11. Respiratory syncytial virus pneumonia among the elderly: an assessment of disease burden.
Han LL; Alexander JP; Anderson LJ
J Infect Dis; 1999 Jan; 179(1):25-30. PubMed ID: 9841818
[TBL] [Abstract][Full Text] [Related]
12. [Perinatal history and hospitalization for bronchiolitis. A comparison with the impact-RSV Study Group].
Bonillo Perales A ; DíezDelgado Rubio J ; Ortega Montes A ; Infante Márquez P ; Jiménez Liria M ; Batlles Garrido J ; López Muñoz J
An Esp Pediatr; 2000 Dec; 53(6):527-32. PubMed ID: 11148149
[TBL] [Abstract][Full Text] [Related]
13. Substantial variability in community respiratory syncytial virus season timing.
Mullins JA; Lamonte AC; Bresee JS; Anderson LJ
Pediatr Infect Dis J; 2003 Oct; 22(10):857-62. PubMed ID: 14551484
[TBL] [Abstract][Full Text] [Related]
14. Respiratory syncytial virus-related bronchiolitis in Puerto Rico.
Molinari Such M; García I; García L; Puig G; Pedraza L; Marín J; Valcárcel M
P R Health Sci J; 2005 Jun; 24(2):137-40. PubMed ID: 16116931
[TBL] [Abstract][Full Text] [Related]
15. Prevalence of respiratory syncytial virus infection in Italian infants hospitalized for acute lower respiratory tract infections, and association between respiratory syncytial virus infection risk factors and disease severity.
Lanari M; Giovannini M; Giuffré L; Marini A; Rondini G; Rossi GA; Merolla R; Zuccotti GV; Salvioli GP;
Pediatr Pulmonol; 2002 Jun; 33(6):458-65. PubMed ID: 12001280
[TBL] [Abstract][Full Text] [Related]
16. Direct cost analyses of palivizumab treatment in a cohort of at-risk children: evidence from the North Carolina Medicaid Program.
Wegner S; Vann JJ; Liu G; Byrns P; Cypra C; Campbell W; Stiles A
Pediatrics; 2004 Dec; 114(6):1612-9. PubMed ID: 15574623
[TBL] [Abstract][Full Text] [Related]
17. Human metapneumovirus infection in young children hospitalized with respiratory tract disease.
Foulongne V; Guyon G; Rodière M; Segondy M
Pediatr Infect Dis J; 2006 Apr; 25(4):354-9. PubMed ID: 16567989
[TBL] [Abstract][Full Text] [Related]
18. Rates of hospitalization for respiratory syncytial virus infection among children in medicaid.
Boyce TG; Mellen BG; Mitchel EF; Wright PF; Griffin MR
J Pediatr; 2000 Dec; 137(6):865-70. PubMed ID: 11113845
[TBL] [Abstract][Full Text] [Related]
19. Intravenous palivizumab and ribavirin combination for respiratory syncytial virus disease in high-risk pediatric patients.
Chávez-Bueno S; Mejías A; Merryman RA; Ahmad N; Jafri HS; Ramilo O
Pediatr Infect Dis J; 2007 Dec; 26(12):1089-93. PubMed ID: 18043443
[TBL] [Abstract][Full Text] [Related]
20. Brief report: respiratory syncytial virus activity--United States, 2004-2005.
Centers for Disease Control and Prevention (CDC)
MMWR Morb Mortal Wkly Rep; 2005 Dec; 54(49):1259-60. PubMed ID: 16358448
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
